AXA Partners with China Biotech Services to Expand Access to Advanced Cancer Treatments
AXA has signed a Memorandum of Understanding (MoU) with China Biotech Services to explore advanced cancer therapies, including Boron Neutron Capture Therapy (BNCT), a highly targeted form of radiotherapy.